NIH-funded research NIH-funded research

Understanding how fetal male germ cells fix DNA breaks

Official title: Mechanisms of Double Strand Break Repair in Fetal Male Germ Cells

Funded at University of North Carolina Charlotte · NIH-11627830 · Data updated 2026-11-12

Researchers are studying how DNA damage in fetal male germ cells is repaired to keep future sperm healthy.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of North Carolina Charlotte
NIH-funded
Lab location1 site (Charlotte, United States)
Project startSeptember 2, 2026
Project endAugust 31, 2029
Funding year2026
Award (this year)$248,901
NIH project number4R00HD117011-03
Project IDNIH-11627830 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are males at risk of heritable germline DNA repair issues or researchers studying fetal germ cell biology; direct patient participation is not specified, but insights may inform future human studies.

Less likely to help

If you are not involved in germline biology or heritable DNA repair research, immediate personal benefits may be limited.

What this research studies

This project focuses on how germ cells in male fetuses repair breakages in their DNA, which could affect future fertility and offspring. It compares repair pathways like non-homologous end joining and homologous recombination in a critical G0 phase before birth. The goal is to uncover mechanisms that keep the germline genome accurate, using human and mouse biology to bridge knowledge from development to potential clinical insights. Findings could inform strategies for reducing heritable genetic errors that impact fertility and offspring health.

Why it matters

Potential benefit: A better understanding of germline DNA repair could lead to ways to protect future children from heritable genetic issues.

How similar studies have gone: Previous work shows that germ cell DNA repair pathways are critical for genome integrity, with ongoing exploration in humans and animals.

Where this research is happening

  • University of North Carolina Charlotte
    Charlotte, United States
    Active

Researchers

  • Principal investigator: Hatkevich, Talia Lee — University of North Carolina Charlotte
  • Study coordinator: Hatkevich, Talia Lee

Related research

Other NIH-funded projects on the same topics.

  • Automated single-cell heart cell measurements to test drugs

    A new automated system will quickly measure electrical signals and beating force in heart cells derived from a patient’s own stem cells to help predict drug safety.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11464806

  • Innate Immune Trigger to Boost Bone Infection Defense

    Researchers are testing a way to wake up the body's own innate immune system to fight stubborn bone infections caused by Staphylococcus aureus, aiming to help people with osteomyelitis fight bacteria more effectively.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11441932

  • Targeting Perp in pancreatic cancer and its muscle wasting

    This NIH grant explores a gene called Perp as a potential target to slow pancreatic cancer growth and reduce cachexia in patients.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11394547

  • Substance P and worsening bone infection from staph bacteria

    Aims to understand if a nerve-related molecule called substance P makes bone infection from Staphylococcus aureus worse.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11384609

  • Deciphering Pemphigus Risk Through Immune Gene Maps

    A study to map the genetic and immune signals that raise the risk of pemphigus, a rare autoimmune skin disease, in adults.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11382943

  • Mucin-1 targeted nanoparticles delivering chemotherapy for pancreatic cancer

    A new targeted nanoparticle system is being developed to deliver chemotherapy directly to pancreatic cancer cells in order to improve treatment outcomes.

    NIH research University of North Carolina Charlotte · Charlotte, United States · NIH-11380928

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.